According to Dr. Paul Alexander:

Three (3) embedded studies raise very exciting potential for NAC and Bromelain as a means to dissolve spike protein. We have been extolling the virtues of NATTOKINASE (natural blood thinner) in support and dissolving spike protein (in TWC’s Spike Recovery product) yet NAC and Bromelain (combination BromAc is revealing enhanced activity against spike protein) deserves mention:


N-acetyl cysteine (NAC), as a nutritional supplement, is a greatly applied antioxidant in vivo and in vitro. NAC is a precursor of L-cysteine that results in glutathione elevation biosynthesis. It acts directly as a scavenger of free radicals, especially oxygen radicals. NAC is a powerful antioxidant. It is also recommended as a potential treatment option for different disorders resulted from generation of free oxygen radicals. Additionally, it is a protected and endured mucolytic drug that mellows tenacious mucous discharges. It has been used for treatment of various diseases in a direct action or in a combination with some other medications.’


‘Bromelain and Acetylcysteine  have synergistic action against glycoproteins by breakage of glycosidic linkages and disulfide bonds.

The study sought to determine the effect of  bromalain and NAC on the spike and envelope proteins and its potential to reduce infectivity in host cells.

Recombinant spike and envelope SARS-CoV-2 proteins were disrupted by BromAc.

Spike and envelope protein disulfide bonds were reduced by Acetylcysteine. In in vitro whole virus culture of both wild-type and spike mutants, SARS-CoV-2 demonstrated a concentration-dependent inactivation from BromAc treatment but not from single agents.’

Article Source:  Dr. Paul Alexander Substack!

Everything You Need to Know about Spike Proteins

Spike proteins are a type of protein found on the surface of viruses. They are named after their characteristic appearance, which resembles a spike or protrusion. These proteins play a crucial role in the virus’s ability to infect and invade host cells.

One of the most well-known examples of spike proteins is the SARS-CoV-2 virus, which is responsible for the COVID-19 pandemic. The virus’s spike proteins are what enable it to bind to and enter human cells, leading to infection. The spike proteins on the virus’s surface attach to receptors on the host cell, allowing the virus to enter and hijack the host cell’s machinery to replicate itself.

Spike proteins are composed of amino acids and are folded into a specific three-dimensional structure that enables them to interact with other molecules. They are typically made up of two subunits, called S1 and S2. The S1 subunit contains the receptor-binding domain (RBD), which binds to the host cell receptor, and the S2 subunit contains the fusion peptide, which allows the virus to fuse with the host cell membrane.

The structure of spike proteins varies between different viruses, but they all share some common features. For example, they are often heavily glycosylated, meaning they have sugar molecules attached to them. This glycosylation can help the virus evade the immune system by masking the protein from recognition by antibodies.

Spike proteins are a key target for vaccines and therapeutics. By inducing an immune response to the spike protein, vaccines can train the immune system to recognize and attack the virus. Many of the COVID-19 vaccines currently in use, such as the Pfizer-BioNTech and Moderna vaccines, use a small piece of the spike protein, called the receptor-binding domain, as their antigen. This antigen is then presented to the immune system, which produces antibodies against it.

Spike proteins are also a target for antiviral drugs. Some drugs, such as monoclonal antibodies, bind to the spike protein and prevent it from interacting with the host cell receptor. This can block the virus’s ability to enter the host cell and replicate itself.

In conclusion, spike proteins are an essential component of many viruses, including SARS-CoV-2. They allow the virus to enter and infect host cells, making them a crucial target for vaccines and therapeutics. Understanding the structure and function of spike proteins is vital for developing effective treatments and controlling the spread of viral diseases. The problem that has arisen in 2023 is that the vaccines were never fully tested, and were never found to be “safe and effected” based upon longitudinal studies. As a result, the world now faces significant a health crisis that might take us decades to resolve.

Related links of Interest: